Unknown

Dataset Information

0

Correction to: Dotinurad: a novel selective urate reabsorption inhibitor as a future therapeutic option for hyperuricemia.

ABSTRACT: In the original publication of the article the presentation of Table 1 was incorrectly published.

SUBMITTER: Kuriyama S 

PROVIDER: S-EPMC7645461 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Correction to: Dotinurad: a novel selective urate reabsorption inhibitor as a future therapeutic option for hyperuricemia.

Kuriyama Satoru S  

Clinical and experimental nephrology 20200301 Suppl 1

In the original publication of the article the presentation of Table 1 was incorrectly published. ...[more]

Similar Datasets

Unknown A clinical pharmacology study of the novel, selective urate reabsorption inhibitor dotinurad in outpatients.
| S-EPMC7066296 | biostudies-literature
Unknown Clinical effects of a selective urate reabsorption inhibitor dotinurad in patients with hyperuricemia and treated hypertension: a multicenter, prospective, exploratory study (DIANA).
| S-EPMC10351195 | biostudies-literature
Unknown Dotinurad: a clinical pharmacokinetic study of a novel, selective urate reabsorption inhibitor in subjects with hepatic impairment.
| S-EPMC7066095 | biostudies-literature
Unknown Comparative study of a novel selective urate reabsorption inhibitor "dotinurad" among patient groups with different stages of renal dysfunction.
| S-EPMC8526486 | biostudies-literature
Unknown The effect for hyperuricemia inpatient of uric acid overproduction type or in combination with topiroxostat on the pharmacokinetics, pharmacodynamics and safety of dotinurad, a selective urate reabsorption inhibitor.
| S-EPMC7066310 | biostudies-literature
Unknown Effects of mild and moderate renal dysfunction on pharmacokinetics, pharmacodynamics, and safety of dotinurad: a novel selective urate reabsorption inhibitor.
| S-EPMC7066277 | biostudies-literature
Unknown Integrated safety studies of the urate reabsorption inhibitor lesinurad in treatment of gout.
| S-EPMC6293483 | biostudies-literature
Unknown Structural Basis for Inhibition of Urate Reabsorption in URAT1.
| S-EPMC11937972 | biostudies-literature
Unknown SLC2A9 (GLUT9) mediates urate reabsorption in the mouse kidney.
| S-EPMC6224025 | biostudies-literature
Unknown Physiology of Hyperuricemia and Urate-Lowering Treatments.
| S-EPMC5990632 | biostudies-literature